<DOC>
	<DOCNO>NCT02377947</DOCNO>
	<brief_summary>This retrospective study adult patient cirrhosis grade 3 4 HE ( West Haven Criteria ) evaluate effectiveness safety lactulose retention enema treatment deep grade HE ( West Haven Criteria ) . The study conduct retrospectively single center multispecialty tertiary care hospital India , lactulose retention enema mainstay management cirrhotic patient grade 3 4 HE ( West Haven criterion ) . Dosing lactulose retention enema study do accord dose described rectal administration lactulose ( India ) : 300ml lactulose mixed 700ml potable water use retention enema ; enema retain 30-60 minute repeat every 4-6 hour patient able take oral medication . This treatment regime also standard protocol management deep grade HE ( West Haven criterion ) study center . The standard treatment protocol deep grade HE ( West Haven criterion ) study center also ensure know contraindication lactulose respected administration lactulose retention enema study patient . The retrospective hospital record patient population interest within past 6 month identify , record use collect data require analysis .</brief_summary>
	<brief_title>A Retrospective Study Assess Effectiveness Safety Lactulose Retention Enema Treatment Cirrhotic Patients With Grade 3 4 ( West Haven Criteria ) Hepatic Encephalopathy ( HE ) ( The RETRO Study )</brief_title>
	<detailed_description>Data collect : Data would collect study part retrospective chart review : 1 . Patient demographic : age , gender , weight 2 . Medical history 3 . Etiology cirrhosis ( alcohol abuse , hepatitis , autoimmune , cryptogenic , ) 4 . Diagnosis cirrhosis 5 . History previous HE ( yes , number episode past ) 6 . Grade HE ( per West-Haven criterion ) admission , 24 hr 48 hour post treatment lactulose 7 . Precipitating factor ( ) HE ( Dehydration , GI bleeding , protein overload , constipation , infection , others ) 8 . Dose duration lactulose enema 9 . Treatment give precipitate factor 10 . Laboratory data haemoglobin , platelet , bilirubin , albumin , AST ( aspartate aminotransferase ) , ALT ( alanine aminotransferase ) , urea , creatinine , sodium , potassium , blood ammonia 11 . Complete reversal deep-grade HE ( &lt; Grade 2 per West-Haven criterion ) ( yes/no ) 12 . Time complete reversal deep-grade HE 13 . Number day hospital 14 . Adverse drug reaction experience patient 15 . Complications experience patient 16 . Other pharmacovigilance relevant information ( OPRI )</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Patients age 18 65 year either gender . Patients admit hospital liver cirrhosis grade 3 grade 4 ( West Haven Criteria ) HE Patients treat lactulose retention enema within 48 hour onset grade 3 4 ( West Haven Criteria ) HE Patients treat agent lactulose retention enema grade 3 4 ( West Haven Criteria ) HE . Patients significant concomitant disease could impair contribute impairment consciousness Patients major neuropsychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Lactulose Retention Enema</keyword>
	<keyword>Hepatic Encephalopathy , Grade 3 4 West Haven Criteria</keyword>
	<keyword>The Retro Study</keyword>
</DOC>